Chiron Behring GmbH & Co – Trademark Portfolio
Entity Type: 03
Chiron Behring GmbH & Co holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include RABAVERT. The owner is based in 35041 Marburg.
Emil-Von-Behring-Str. 76
35041 Marburg , DE
Showing of trademarks Trademarks
Trademark Classifications
Chiron Behring GmbH & Co's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Chiron Behring GmbH & Co have?
Chiron Behring GmbH & Co has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 1 cancelled.
What trademark classes does Chiron Behring GmbH & Co file in?
Chiron Behring GmbH & Co files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Chiron Behring GmbH & Co's most well-known trademarks?
Chiron Behring GmbH & Co's registered trademark portfolio includes well-known marks such as RABAVERT. These are among 1 currently registered trademark in the portfolio.
What is Chiron Behring GmbH & Co's trademark registration success rate?
Chiron Behring GmbH & Co has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.